Effects of green tea on carcinogen-induced hepatic CYP1As in C57BL/6 mice

M Yang1, M Yoshikawa, K Arashidani

  • 1Department of Preventive Medicine/Cancer Research Institute, Seoul National University College of Medicine, 28 Yongon-Dong Chongno-Gu, 110-799 Seoul, Korea. myang@snu.ac.kr

Insights

Green tea (GT) drinking may prevent cancer by altering how the body processes carcinogens. Whole GT enhances carcinogen metabolism via pathways other than CYP1As, suggesting a different mechanism than GT polyphenols.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Toxicology

Background:

  • Green tea (GT) consumption is linked to cancer chemoprevention.
  • GT components, like polyphenols, may inhibit CYP1A enzymes, which activate certain carcinogens.
  • Investigating whole GT's effect on CYP1A-mediated carcinogen metabolism is crucial for understanding population-level chemoprevention.

Purpose of the Study:

  • To determine if whole green tea (GT) drinking alters hepatic CYP1A levels and activity in mice exposed to a CYP1A-inducing carcinogen.
  • To clarify the role of CYP1A enzymes in the chemopreventive effects of whole GT against carcinogens bioactivated by CYP1As.

Main Methods:

  • Mice (C57 BL/6) were treated with green tea (GT) before and during exposure to 3-methylcholanthrene (MC), a CYP1A inducer.
  • Hepatic CYP1A levels and ethoxyresorufin-O-demethylase (EROD) activity were measured.
  • Monoclonal antibodies and western blot analysis were used to identify specific enzyme contributions.

Main Results:

  • Green tea (GT) drinking alone induced hepatic CYP1As and enhanced MC-induced EROD activity.
  • Enhanced EROD activity was not attributed to increased CYP1A levels, as shown by antibody and western blot studies.
  • These findings indicate GT modulates other microsomal enzymes, not primarily CYP1As, in biotransforming carcinogens.

Conclusions:

  • Whole green tea (GT) chemoprevention against CYP1A-bioactivated carcinogens may involve mechanisms distinct from CYP1A inhibition by GT polyphenols.
  • GT appears to enhance the biotransformation of carcinogens through pathways independent of CYP1A modulation.
  • Further research is needed to elucidate the specific enzymes and pathways involved in GT's chemopreventive effects.